Pharmacologic Actions: News and Research on Anti-Obesity Agents

MeSH tree: D27.505.954.203

Biden plan to expand obesity drug coverage is rejected

The Trump administration has decided not to expand Medicare and Medicaid coverage for popular obesity drugs, blocking a Biden administration initiative that could have helped millions of Americans access the medications.

Weighing the high cost of obesity reduction drugs

University of Chicago researchers assessed the long-term health outcomes and cost-effectiveness of four antiobesity medications compared to lifestyle modification alone. Results indicate that tirzepatide and semaglutide provide ...

Prescriptions for obesity management drugs increasing

Prescriptions of obesity management drugs (OMDs) have increased, and these increasing trends are associated with online search trends, according to a study published online Jan. 29 in JAMA Network Open.

Moderate exercise keeps appetite at bay, says research

A recent study involving researchers at Murdoch University's Health Futures Institute has revealed that moderate-intensity exercise can significantly influence appetite-related hormones and perceptions in males with obesity.

page 3 from 7